LNTH
Lantheus Holdings, Inc. Health Care In Vitro & In Vivo Diagnostic Substances Russell 3000
$100.46Close
$6.5BMarket cap
$50.69 – $110.9452-week range
Nov 5, 2026Next report
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 85 · stronger than 85% of stocks over 12 months
- Tight base near its pivot pullbacks 11% → 10% → 2% → 1%; 0.0% above its $100.46 pivot
Cautions
- Earnings shrinking EPS −1% year on year
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
9%
1wk
up 0.7%
price change
1mo
up 0.9%
price change
12-month return
up 81%
market up 11% ·
its own up 69%
F-score
5 / 9
Mixed
Altman Z
5.31
Low risk
P/E
27.8×
price / earnings
PEG
—
P/E / EPS growth
P/B
6.0×
price / book
Earnings yield
up 4.6%
EBIT / enterprise value
Cheaper than
55%
of the market · around average
Revenue growth
up 1%
year on year
EPS growth
down 1%
latest quarter · -77 pts
Sales growth
up 3%
latest quarter · +1 pts
ROE
up 21%
return on equity
Free cash margin
up 25%
$390.1M FCF
D/E
0.52
long-term debt / equity
Net debt / EBITDA
0.6×
Interest cover
—EBIT / interest
Piotroski tests
- profitability slipped from last year
- short-term liquidity weakened
- gross margin narrowed
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- no new shares issued
Trade setup
ATR%
0.4%
$0.42 a day · 2×ATR $99.62
RS
85 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
0.4×
vs 50-day average
Up/down volume
0.70
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Contractions
4
11% → 10% → 2% → 1%
Pivot
$100.46
0.0% above
Volume dry-up
1.1×
10 vs 50 sessions
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Gross margin narrowing Gross margin fell from 64.4% to 61.1%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026-1% vs market2 sessions after results
Financials
- Gross 61%
- Net 15%
- Free cash 25%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $339.4M | $425.2M | $935.1M | $1.3B | $1.5B | $1.5B |
| Gross margin | 41% | 44% | 62% | 55% | 64% | 61% |
| Operating income | -$4.2M | -$60.8M | $36.2M | $364.6M | $457.0M | $310.8M |
| Net income | -$13.5M | -$71.3M | $28.1M | $326.7M | $312.4M | $233.6M |
| Net margin | -4% | -17% | 3% | 25% | 20% | 15% |
| Earnings per share | -$0.25 | -$1.06 | $0.40 | $4.65 | $4.36 | $3.41 |
| Free cash flow | $16.4M | $53.9M | $21.8M | $259.9M | $544.8M | $390.1M |
| Free cash margin | 5% | 13% | 2% | 20% | 36% | 25% |
| Cash | $79.6M | $98.5M | $415.7M | $713.7M | $912.8M | $359.1M |
| Long-term debt | $197.7M | $163.1M | $557.7M | $562.5M | $566.3M | $569.4M |
| Shareholders' equity | $514.2M | $464.4M | $447.1M | $815.9M | $1.1B | $1.1B |
| Shares outstanding | 66.88m | 67.74m | 68.85m | 69.86m | 68.45m | 64.59m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 6, 2025 | Quarterly ↗ | Jun 30, 2025 | 37d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 26, 2025 | Annual ↗ | Dec 31, 2024 | 57d |
| Nov 6, 2024 | Quarterly ↗ | Sep 30, 2024 | 37d |
| Jul 31, 2024 | Quarterly ↗ | Jun 30, 2024 | 31d |
| May 2, 2024 | Quarterly ↗ | Mar 31, 2024 | 32d |
| Feb 22, 2024 | Annual ↗ | Dec 31, 2023 | 53d |
| Nov 2, 2023 | Quarterly ↗ | Sep 30, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 22, 2026 | Other events ↗ |
| Oct 14, 2026 | Shareholder vote ↗ |
| Oct 2, 2026 | Other events ↗ |
| Sep 21, 2026 | Other events ↗ |
| Aug 6, 2026 | Results ↗ |
| Aug 4, 2026 | Material agreement · Director or officer change ↗ |
| Aug 3, 2026 | Regulation FD · Other events ↗ |
| May 7, 2026 | Results ↗ |
| May 1, 2026 | Holder rights changed · Director or officer change · Charter or bylaws · Shareholder vote ↗ |
| Feb 26, 2026 | Results ↗ |
| Nov 12, 2025 | Director or officer change ↗ |
| Nov 6, 2025 | Results · Director or officer change · Regulation FD ↗ |